IP Library Granted Patent US 9,404,118
Granted Patent B2
US 9,404,118 · App. 14/238,248 · Granted Aug 2, 2016

Patent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,404,118
App. No.
14/238,248
Granted
Aug 2, 2016
Kind
B2
Abstract

The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.

Claims (23)

1. An genetically modified Pichia ciferrii cell, wherein said genetically modified Pichia ciferrii cell has, compared to its wild type, a reduced activity of an E 1 enzyme encoded by the intron-free nucleic acid sequences selected from the group consisting of

A) SEQ ID NO: 1, and

B) a sequence which is at least 90% identical to SEQ ID NO: 1, wherein said activity of said E 1 enzyme is the catalysis of the reaction 5,10-methylenetetrahydrofolate+L-glycine+H 2 O to tetrahydrofolate+L-serine.

2. The genetically modified Pichia ciferrii cell according to claim 1 , wherein said reduction of enzymatic activity is achieved by modifying a gene comprising the nucleic acid sequence set forth in SEQ ID NO: 1, wherein the modification is selected from the group consisting of insertion of foreign DNA into the gene, deletion of at least a portion of the gene, point mutations in the gene sequence, exposing the gene to the influence of RNA interference, and replacement of a portion of the gene with foreign DNA.

3. The genetically modified Pichia ciferrii cell according to claim 2 , wherein said foreign DNA is a selection marker gene that can be removed without leaving a trace and which leaves a deletion in the target gene.

4. The genetically modified Pichia ciferrii cell according to claim 1 , wherein the Pichia ciferrii cell is obtained from strains selected from the group consisting of

Pichia ciferrii NRRL Y-1031 F-60-10, and

Pichia ciferrii CS.PCΔPro2.

5. The genetically modified Pichia ciferrii cell according to claim 1 , characterized in that the cell further has, compared to its wild type, an increased enzymatic activity of an enzyme E 2 , wherein said enzyme E 2 catalyzes the reaction of sphinganine to phytosphingosine.

6. A method of producing an isolated Pichia ciferrii cell according to claim 1 , said method comprising the steps of:

I) providing an isolated Pichia ciferrii cell, and

II) modifying at least one gene comprising any of the sequences selected from the nucleic acid sequence groups A) and B) specified in claim 1 by insertion of foreign DNA into the gene, deletion of at least parts of the gene, point mutations in the gene sequence, exposing the gene to the influence of RNA interference, and replacement of parts of the gene with foreign DNA.

7. A method of producing sphingoid bases and sphingolipids, said method comprising the steps of

acting the cell according to claim 1 with a medium including a carbon source,

b) culturing the cell under conditions which enable the cell to produce sphingoid bases and sphingolipids from said carbon source, and

c) optionally isolating the sphingoid bases and sphingolipids produced.

8. The genetically modified Pichia ciferrii cell according to claim 2 , wherein said replacement of a portion of the gene with foreign DNA is of the promoter region.

9. The genetically modified Pichia ciferrii cell according to claim 5 , wherein said enzyme E 2 is a sphinganine C4-hydroxylase.

10. The genetically modified Pichia ciferrii cell according to claim 9 , wherein said sphinganine C4-hydroxylase is encoded by SEQ ID NO: 17.

11. The method according to claim 6 , wherein said foreign DNA is DNA coding for a selection marker gene.

12. The method according to claim 6 , wherein said replacement of parts of the gene with foreign DNA is of the promoter region.

13. The genetically modified Pichia ciferrii cell of claim 1 , wherein said intron-free nucleic acid sequences consists of a sequence that is at least 95% identical to SEQ ID NO: 1.

14. The genetically modified Pichia ciferrii cell of claim 13 , wherein said intron-free nucleic acid sequences consists of a sequence that is at least 99% identical to SEQ ID NO: 1.

Assignments (2)
CHANGE OF NAME Recorded Apr 16, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 052422/0342 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2014
From: KÖHLER, TIM; SCHORSCH, CHRISTOPH; BOLES, ECKHARD; ANDREA, HEIKO; FARWICK, MIKE; SCHAFFER, STEFFEN
To: EVONIK DEGUSSA GMBH
Reel/Frame 032193/0399 →